Literature DB >> 24459776

[National consensus of diagnosis and treatment of non-small cell lung cancer].

Oscar Arrieta1, Enrique Guzmán-de Alba2, Luis Felipe Alba-López3, Alicia Acosta-Espinoza4, Jorge Alatorre-Alexander2, José Francisco Alexander-Meza5, Silvia Rosa Allende-Pérez6, Salvador Alvarado-Aguilar6, Margarita E Araujo-Navarrete7, Luis Marcelo Argote-Greene8, Cinthia Alejandra Aquino-Mendoza6, Alma Magdalena Astorga-Ramos9, Horacio Austudillo-de la Vega10, Alejandro Avilés-Salas6, Luis Javier Barajas-Figueroa11, Nimbe Barroso-Quiroga12, Mónica Blake-Cerda6, Paula Anel Cabrera-Galeana13, Germán Calderillo-Ruíz6, Alma Delia Campos-Parra6, Ana María Cano-Valdez6, Daniel Capdeville-García14, Graciano Castillo-Ortega15, Catalina Casillas-Suárez16, Patricia Castillo-González2, José Francisco Corona-Cruz6, María Elma Correa-Acevedo6, Séfora Sonciry Cortez-Ramírez2, Jhony Alberto de la Cruz-Vargas17, Jaime G de la Garza-Salazar6, María Dolores de la Mata-Moya6, María Eugenia Domínguez-Flores2, Hugo Ricardo Domínguez-Malagón6, Luis Manuel Domínguez-Parra18, Alfredo Domínguez-Peregrina19, Jaime Durán-Alcocer20, María Isabel Enríquez-Aceves21, Abelardo Elizondo-Ríos22, Moisés Dante Escobedo-Sánchez2, Pablo Espinosa-Mireles de Villafranca6, Alberto Flores-Cantisani23, Juan Pablo Flores-Gutiérrez24, Francisco Franco-Marina5, Edwin Efraín Franco-González25, Ramón Antonio Franco-Topete26, Homero Fuentes-de la Peña27, Susana Galicia-Amor2, Dolores Gallardo-Rincón6, Armando Gamboa-Domínguez8, Jorge García-Andreu28, Claudia María García-Cuéllar6, María Cecilia García-Sancho-Figueroa2, Rogelio García-Torrentera2, Raquel Gerson-Cwilich29, Arturo Gómez-González30, León Green-Schneeweiss16, María del Rocío Guillén-Núñez6, Hilda Gutiérrez-Velázquez3, Carlos Ibarra-Pérez16, Edgardo Jiménez-Fuentes6, Paula Juárez-Sánchez6, Alejandro Juárez-Ramiro31, Javier Kelly-García10, Roberto Kuri-Exsome32, Jesús Miguel Lázaro-León16, Eucario León-Rodríguez8, Sara Llanos-Osuna33, Sara Llanos-Osuna33, Ulises Loyola-García13, José Sullivan López-González2, Francisco Javier López y de Antuñano34, Marco Antonio Loustaunau-Andrade35, Eleazar Omar Macedo-Pérez10, Limberth Machado-Villarroel11, Manuel Magallanes-Maciel36, Luis Martínez-Barrera29, Jorge Martínez-Cedillo17, Gloria Martínez-Martínez10, Alfredo Medina-Esparza27, Abelardo Meneses-García6, Alejandro Mohar-Betancourt6, Jaime Morales Blanhir8, José Morales-Gómez2, Daniel Motola-Kuba3, Marcela Patricia Nájera-Cruz2, Carolina del Carmen Núñez-Valencia6, María Angélica Ocampo-Ocampo16, María Dolores Ochoa-Vázquez37, Carlos A Olivares-Torres38, Andrés Palomar-Lever39, Mario Patiño-Zarco6, Rogelio Pérez-Padilla2, Yolanda Rocío Peña-Alonso40, Alfredo Rafael Pérez-Romo16, Mario Aquilino Pérez10, Paulo Martín Pinaya-Ruíz41, María Adela Pointevin-Chacón42, Juan José Poot-Braga43, Rodolfo Posadas-Valay44, Marcelino Ramirez-Márquez45, Ivonne Reyes-Martínez8, Julio Robledo-Pascual46, Jerónimo Rodríguez-Cid3, Carlos Enrique Rojas-Marín6, Elizabeth Romero-Bielma2, Jaime Ernesto Rubio-Gutiérrez47, Julia Angelina Sáenz-Frías48, Miguel Angel Salazar-Lezama2, Karla Sánchez-Lara3, Raúl Sansores Martínez2, Patricio Santillán-Doherty5, Juan Alejandro-Silva10, José Luis Téllez-Becerra2, Vinicio Toledo-Buenrostro49, Luis Torre-Bouscoulet2, Laura Torecillas-Torres32, Marineé Torres16, Víctor Tovar-Guzmán50, Jenny Georgina Turcott-Chaparro6, Jesús Javier Vázquez-Cortés51, María Eugenia Vázquez-Manríquez2, Natalia Vilches-Cisneros24, José Felipe Villegas-Elizondo26, Mauro M Zamboni52, Jesús Zamora-Moreno6, Juan W Zinser-Sierra6.   

Abstract

Mexican specialists in oncology, oncologic surgery, thoracic surgery, pneumology, pathology, molecular biology, anesthesiology, algology, psychology, nutrition, and rehabilitation (all of them experts in lung cancer treatment) in order to develop the National Consensus on Lung Cancer. The consensus has been developed as an answer to the need of updated Mexican guidelines for the optimal treatment of the disease, as well as to the requirements that such guidelines be established by multidisciplinary panel, depicting the current attention given to cancer lung cases in Mexico. Thus, this paper analyses the epidemiological review, screening, diagnosis, staging, pathology, translational medicine, and the suitable therapies for early, locally advanced, and metastatic disease in the first, second, and third lines of management, as well as rehabilitation and palliative measures.

Entities:  

Mesh:

Year:  2013        PMID: 24459776

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  21 in total

1.  Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.

Authors:  Oscar Arrieta; Martha De la Torre-Vallejo; Diego López-Macías; David Orta; Jenny Turcott; Eleazar-Omar Macedo-Pérez; Karla Sánchez-Lara; Laura-Alejandra Ramírez-Tirado; Vickie E Baracos
Journal:  Oncologist       Date:  2015-07-14

2.  A novel biomarker protein panel for lung cancer, a promising first step.

Authors:  Camilo Molina-Romero; Edgar Vergara; Oscar Arrieta
Journal:  Transl Lung Cancer Res       Date:  2018-12

3.  The reality of complexity: concomitant genomic alterations in patients with EGFR mutations.

Authors:  Andrés F Cardona; Zyanya Lucia Zatarain-Barrón; Leonardo Rojas; Oscar Arrieta
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

4.  Extending the curve: survival of EGFR-mutated lung cancer patients in the 21st century.

Authors:  Feliciano Barrón; Zyanya Lucia Zatarain-Barrón; Andrés F Cardona; Oscar Arrieta
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.

Authors:  Saé Muñiz-Hernández; Sara Huerta-Yepez; Norma Hernández-Pedro; Laura-Alejandra Ramírez-Tirado; Alejandro Aviles-Salas; Altagracia Maldonado; Daniel Hernández-Cueto; Guillermina Baay-Guzmán; Oscar Arrieta
Journal:  Int J Clin Oncol       Date:  2016-06-15       Impact factor: 3.402

6.  Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer.

Authors:  Alejandro Avilés-Salas; Saé Muñiz-Hernández; Héctor Aquiles Maldonado-Martínez; José G Chanona-Vilchis; Laura-Alejandra Ramírez-Tirado; Norma HernáNdez-Pedro; Rita Dorantes-Heredia; José Manuel RuíZ-Morales; Daniel Motola-Kuba; Oscar Arrieta
Journal:  Oncol Lett       Date:  2016-12-16       Impact factor: 2.967

7.  The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial.

Authors:  Jenny G Turcott; María Del Rocío Guillen Núñez; Diana Flores-Estrada; Luis F Oñate-Ocaña; Zyanya Lucia Zatarain-Barrón; Feliciano Barrón; Oscar Arrieta
Journal:  Support Care Cancer       Date:  2018-03-17       Impact factor: 3.603

8.  Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial.

Authors:  Oscar Arrieta; Graciela Cruz-Rico; Enrique Soto-Perez-de-Celis; Laura-Alejandra Ramírez-Tirado; Enrique Caballe-Perez; Jorge-Negueb Martínez-Hernández; Ivan Martinez-Alvarez; Giovanny Soca-Chafre; Eleazar Omar Macedo-Pérez; Horacio Astudillo-de la Vega
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493

9.  Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation.

Authors:  Feliciano Barrón; Andrés F Cardona; Luis Corrales; Laura-Alejandra Ramirez-Tirado; Enrique Caballe-Perez; Gisela Sanchez; Diana Flores-Estrada; Zyanya Lucia Zatarain-Barrón; Oscar Arrieta
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

10.  Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of Mexico.

Authors:  Oscar Arrieta; Roger Humberto Quintana-Carrillo; Gabriel Ahumada-Curiel; Jose Francisco Corona-Cruz; Elma Correa-Acevedo; Juan Zinser-Sierra; Dolores de la Mata-Moya; Alejandro Mohar-Betancourt; Vicente Morales-Oyarvide; Luz Myriam Reynales-Shigematsu
Journal:  Tob Induc Dis       Date:  2015-02-04       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.